NMPA Approval

Recombinant Coagulation Factor VIII for Injection

Approval Number

国药准字SJ20240037

Registration Date

August 13, 2024

Drug Information

Generic Name

注射用重组人凝血因子Ⅷ

Trade Name

凝唯

Dosage Form

注射剂

Strength

500 IU/瓶

Drug Type

生物制品

Registration Date

August 13, 2024

Expiry Date

August 12, 2029

Company Address

Lars Forssells gata 23, 112 75 Stockholm, Sweden

Company Address

Lars Forssells gata 23, 112 75 Stockholm, Sweden

Empowering clinical research with data-driven insights and AI-powered tools.

注射用重组人凝血因子Ⅷ - NMPA 批准文号 | MedPath